Logo

Exagen

People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Jan. 23, 2023.

Earnings Roundup: Waters, Personalis, Opko Health, Biodesix, Exagen

Waters, Personalis, Opko Health, Biodesix, and Exagen reported quarterly financial results this week.

Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection

The assays under development will segment patients according to gene expression in their synovial tissue biopsies to personalize therapy selection.

IPO Window Wide Open for Dx, Genomics Companies
Premium

Industry experts say a receptive market and investor interest in new technologies have spurred the increase in genomics tools and molecular diagnostics IPOs. 

Exagen Records Sharp Increase in Revenues for First Nine Months of 2014

NEW YORK (GenomeWeb) – Exagen Diagnostics said in a regulatory document that its revenues through the first nine months of 2014 grew almost four-fold year over year.
Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.